Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Anxiety in PDD
NCT01302964Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2010
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirtazapine in anxiety disorder, sponsored by Massachusetts General Hospital. Started Aug 2010; status: completed.
02
Drugs
mirtazapine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01302964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302964.